文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病

异常性瘙痒:一种严重的瘙痒形式

Alloknesis: a severe form of itch.
PubMed 文献 · Br J Dermatol · 2026-01-01

本文综述异常性瘙痒(alloknesis),指通常不引起瘙痒的轻机械刺激(如衣物接触)在慢性瘙痒患者中诱发瘙痒。该症状主要见于特应性皮炎,也可存在于其他疾病,负担重但临床认识不足,目前主要用 von Frey 纤维诊断且缺乏验证问卷。其机制涉及外周和中枢敏化,机械 labelled 通路与多模态通路均汇聚于脊髓 GRP-GRP 受体通路,减轻其影响应成为治疗目标,但尚无临床试验。

要点

  • 异常性瘙痒由轻机械刺激诱发,见于慢性瘙痒患者,不等同于生理性机械性瘙痒。
  • 主要见于特应性皮炎,也可存在于其他慢性瘙痒疾病,显著影响生活质量。
  • 诊断主要用 von Frey 纤维,缺乏验证问卷,临床认识与主动评估不足。

核心结论

  • 异常性瘙痒是慢性瘙痒患者中由轻机械刺激诱发的严重瘙痒形式,应作为治疗目标。
  • 其发生与外周和中枢敏化有关,但中枢敏化的作用仍不清楚。
  • 目前尚无临床试验针对异常性瘙痒进行评估,是新兴研究领域。

研究设计与样本

  • 本文为综述,围绕异常性瘙痒的定义、诊断、机制与临床意义进行阐述。

主要发现

  • 异常性瘙痒主要见于特应性皮炎患者,也可能存在于其他多种疾病。
  • 异常性瘙痒与机械性瘙痒不同,前者与瘙痒敏化相关且见于病理状态,后者为生理现象。
  • 低阈值机械感受器与脊髓中间神经元的相互作用在异常性瘙痒中尤为重要。
  • 机械 labelled 通路与多模态通路均参与机械性异常性瘙痒,并汇聚于脊髓 GRP-GRP 受体化学瘙痒通路。
  • 多模态通路通过机械敏感离子通道 PIEZO1 转导轻机械刺激。

关键数值与推荐

  • 慢性瘙痒指持续时间超过 6 周。
  • 异常性瘙痒目前主要使用 von Frey 纤维诊断,尚缺乏验证问卷。

临床怎么用

  • 临床应主动询问慢性瘙痒患者是否因衣物或他人接触等轻机械刺激诱发瘙痒。
  • 可用 von Frey 纤维评估异常性瘙痒,并重视其对生活质量的影响。
  • 减少异常性瘙痒的发生与影响应纳入慢性瘙痒的治疗目标。

局限性

  • 异常性瘙痒在医护人员和患者中认识不足,常未被主动检查。
  • 缺乏验证问卷,诊断方法有限。
  • 尚无临床试验评估异常性瘙痒。
  • 中枢敏化在异常性瘙痒中的作用仍不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alloknesis refers to itch caused by stimuli that do not normally induce itch, particularly light mechanical stimuli, such as contact with clothes or other human bodies. This symptom occurs in patients who are affected by chronic itch. While alloknesis has been mainly described in patients with atopic dermatitis, it is probably present in numerous other conditions and can induce a severe burden. To date, it has mainly been diagnosed using von Frey filaments and validated questionnaires are lacking. Alloknesis differs from mechanical pruritus as it is linked to sensitization to pruritus and therefore occurs in pathological conditions, whereas mechanical pruritus (triggered by the presence of insects on the skin, for example) is a physiological phenomenon. While the role of central sensitization to pruritus in alloknesis is still poorly understood, the role of peripheral sensitization is becoming clearer. Interactions between low-threshold mechanoreceptors and spinal interneurons have a particularly important function. Both the mechanical labelled pathway and the polymodal pathway have been shown to contribute to mechanical alloknesis. The mechanical labelled pathway comprises dedicated primary sensory neurons, spinal interneurons and projection neurons that are functionally distinct from those involved in chemical itch. The polymodal pathway relies on a subset of primary sensory neurons traditionally associated with chemical itch, which can also transduce light mechanical stimuli through the activation of the mechanosensitive ion channel PIEZO1. Both converge onto the gastrin-releasing peptide (GRP)-GRP receptor chemical itch pathway in the spinal cord. Alloknesis is largely unknown to healthcare professionals and even less well known to patients, and is not actively investigated. Reducing the impact and occurrence of alloknesis should be a therapeutic goal. To date, it has not been investigated in clinical trials. A novel research domain is emerging concerning this symptom, which exerts a substantial impact on the daily lives of numerous patients. Alloknesis refers to itch caused by changes in the environment that do not normally induce itch. Examples of such changes include contact with clothing or other human bodies. This symptom occurs in patients who experience chronic itch (i.e. lasting more than 6 weeks). Alloknesis has been mainly described in people with atopic dermatitis. It can also be present in other conditions. It can have a significant impact on a person’s quality of life. Mechanical pruritus is a normal phenomenon (e.g. triggered by the presence of insects on the skin). Alloknesis is distinct from mechanical pruritus, as it involves sensitization. The nervous system becomes overly responsive in conditions associated with chronic pruritus. This review article describes alloknesis. The condition is largely unknown to healthcare professionals and patients. This means that it is not actively investigated. Reducing the impact and occurrence of alloknesis should be a therapeutic goal. Until now, alloknesis has not been investigated in clinical trials. Here, we discuss a new field of research which is developing for alloknesis. This research could profoundly affect the daily lives of patients living with the condition. A better understanding of alloknesis would allow for the development of adapted treatments.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Talagas M, Le Garrec R, Le Bon-Jégo M, et al. Alloknesis: a severe form of itch. Br J Dermatol. 2026. PMID: 40884188. doi:10.1093/bjd/ljaf337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。